NO992500L - 2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister - Google Patents

2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister

Info

Publication number
NO992500L
NO992500L NO992500A NO992500A NO992500L NO 992500 L NO992500 L NO 992500L NO 992500 A NO992500 A NO 992500A NO 992500 A NO992500 A NO 992500A NO 992500 L NO992500 L NO 992500L
Authority
NO
Norway
Prior art keywords
imidazolinylaminobenzoxazole
alfa
compounds useful
adrenoceptor agonists
adrenoceptor
Prior art date
Application number
NO992500A
Other languages
English (en)
Other versions
NO992500D0 (no
NO313755B1 (no
Inventor
Raymond Todd Henry
Russell James Sheldon
William Lee Seibel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992500D0 publication Critical patent/NO992500D0/no
Publication of NO992500L publication Critical patent/NO992500L/no
Publication of NO313755B1 publication Critical patent/NO313755B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19992500A 1996-11-25 1999-05-25 2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister NO313755B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3178796P 1996-11-25 1996-11-25
PCT/US1997/020803 WO1998023611A1 (en) 1996-11-25 1997-11-21 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Publications (3)

Publication Number Publication Date
NO992500D0 NO992500D0 (no) 1999-05-25
NO992500L true NO992500L (no) 1999-07-26
NO313755B1 NO313755B1 (no) 2002-11-25

Family

ID=21861392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992500A NO313755B1 (no) 1996-11-25 1999-05-25 2-imidazolinylaminobenzoksazolforbindelser anvendelige som <alfa>-2 adrenoceptoragonister

Country Status (18)

Country Link
US (1) US6110952A (no)
EP (1) EP0944622A1 (no)
JP (1) JP2001506601A (no)
KR (1) KR20000069128A (no)
AU (1) AU736992B2 (no)
BR (1) BR9713537A (no)
CA (1) CA2272683A1 (no)
CO (1) CO4910150A1 (no)
CZ (1) CZ183699A3 (no)
HU (1) HUP0002966A3 (no)
ID (1) ID22060A (no)
IL (1) IL130094A (no)
NO (1) NO313755B1 (no)
PE (1) PE16599A1 (no)
SK (1) SK74999A3 (no)
TR (1) TR199901486T2 (no)
WO (1) WO1998023611A1 (no)
ZA (1) ZA9710579B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0002966A3 (en) * 1996-11-25 2001-10-29 Procter & Gamble 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
EP1815206B1 (en) * 2004-10-13 2016-04-06 PTC Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US20100202979A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US20100028266A1 (en) * 2008-08-01 2010-02-04 Alpha Synergy Development. Inc. Composition and methods for treating allergic response
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US20100197694A1 (en) * 2008-08-01 2010-08-05 Gerald Horn Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US20110003823A1 (en) * 2008-08-01 2011-01-06 Alpha Synergy Development, Inc. Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US20100203165A1 (en) 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
JP6052685B2 (ja) * 2011-07-25 2016-12-27 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ α２アドレナリン受容体の調節因子としてのＮ−（イミダゾリジン−２−イリデン）−ヘテロシクロペンタ［ｂ］ピリジン誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3830804A (en) * 1972-11-20 1974-08-20 Eastman Kodak Co Fluorescent(pyrimidinotriazolyl)-2-styrylbenzoxazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
FR2521140A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives d'imidazolidine, leur preparation et leur application en therapeutique
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
GB9110017D0 (en) * 1991-05-09 1991-07-03 Nat Res Dev Spectroscopic investigation using organometallic compounds
EP0741709B1 (en) * 1994-01-24 2001-07-25 Allergan Sales, Inc. Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
WO1996004270A1 (en) * 1994-08-04 1996-02-15 Synaptic Pharmaceutical Corporation Novel benzimidazole derivatives
KR100215541B1 (ko) * 1996-04-19 1999-08-16 박원훈 벤족사졸계 비선형 광학 유도체 및 이들로부터 얻어진고분자
HUP0002966A3 (en) * 1996-11-25 2001-10-29 Procter & Gamble 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
SK74999A3 (en) 2000-02-14
PE16599A1 (es) 1999-03-12
AU736992B2 (en) 2001-08-09
ZA9710579B (en) 1998-06-25
IL130094A (en) 2001-09-13
HUP0002966A3 (en) 2001-10-29
CZ183699A3 (cs) 1999-09-15
HUP0002966A2 (hu) 2001-09-28
CA2272683A1 (en) 1998-06-04
AU5438298A (en) 1998-06-22
WO1998023611A1 (en) 1998-06-04
JP2001506601A (ja) 2001-05-22
TR199901486T2 (xx) 1999-10-21
CO4910150A1 (es) 2000-04-24
KR20000069128A (ko) 2000-11-25
EP0944622A1 (en) 1999-09-29
NO992500D0 (no) 1999-05-25
BR9713537A (pt) 2000-03-21
ID22060A (id) 1999-08-26
IL130094A0 (en) 2000-02-29
NO313755B1 (no) 2002-11-25
US6110952A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
NO992470D0 (no) 2-amidazolinyl-amino-indolforbindelser anvendelige som &lt;alfa&gt;-2-adreno-reseptoragonister
NO992498D0 (no) Guanidinylheterocykelforbindelser anvendelige som &lt;alfa&gt;-2 adrenoceptoragonister
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DE69733506D1 (de) Schmierende Zusammensetzung
BR9509760A (pt) Composto
DE69915289D1 (de) Kühlvorrichtung
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO992500L (no) 2-imidazolinylaminobenzoksazolforbindelser anvendelige som &lt;alfa&gt;-2 adrenoceptoragonister
ITRM940002A0 (it) Composizione orale.
DE69936208D1 (de) Modifiziermittel enthaltende zusammensetzung
NO983594D0 (no) Heterosykliske tioetere som additiver for smöremidler
NO20012526D0 (no) Sammensetninger som innbefatter cefuroksimaksetil
DE69700310D1 (de) Rostschutzzusammensetzung
DE59910800D1 (de) Kühler
NO20013013D0 (no) &lt;alfa&gt;v&lt;beta&gt;6-integrininhibitorer
FR2657351B1 (fr) Compose organosilicique.
NO992502D0 (no) 2-Imidazolinylaminoindazolforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister
NO992503L (no) Guanidinylamino heterocykelforbindelser nyttige som &lt;alfa&gt;-2 adrenerge reseptoragonister
NO995030D0 (no) 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som &lt;alfa&gt;-2-adrenoseptoragonister
DE69934143D1 (de) Acrylkautschukmischung
ZA9710574B (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists.
IT1275802B1 (it) Composizione di interferone
NO20010280L (no) &lt;Alfa&gt;-aminosyrefenylesterderivater
FIU980429U0 (fi) Voiteluainekoostumus
ITTO940841A0 (it) Lampada per uso domestico, utilizzabile anche come lampada di emergen-za ad intervento automatico